Virigen (Testosterone)

Quick links to important sections

Virigen (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Virigen (Testosterone)

Virigen is a medication containing a derivative of the naturally occurring C₁₉-steroid sex hormone Testosterone, which functions as the principal androgen in the body. It is formally classified as an Androgen and is considered an Anabolic steroid due to its role in tissue growth and repair.


Quick Facts

Property Description
Active Ingredient Testosterone undecanoate (or other Testosterone ester)
Form Typically Oral Capsule or Injectable Solution
Pharmacological Class Androgen, Anabolic steroid
Common Use Hormone replacement for Testosterone deficiency
Origin Synthetic derivative of an endogenous hormone

What Type of Medicine is Virigen (Testosterone)?

Virigen is categorized as an Androgen and an Anabolic steroid used primarily for hormone replacement therapy. Its active component is a derivative of Testosterone, which is a recognized endogenous hormone essential for the development and maintenance of masculine traits. The pharmaceutical product is a synthetic derivative designed to effectively supplement the body's deficient production of the hormone, thereby correcting the underlying chemical imbalance. This classification is rooted in its fundamental physiological action as an Androgen Receptor Agonist, which means it directly engages the same biological pathways as natural Testosterone. This means the medicine works by taking the place of the body's natural hormone when it is lacking.


Understanding the Composition and Drug Form

The medication utilizes an ester derivative of the active ingredient, most commonly Testosterone undecanoate, which is prepared in a specialized vehicle. Testosterone undecanoate is a single-active ingredient product where the hormone has been chemically modified to improve its absorption and therapeutic profile. Because this compound is highly lipophilic, it is typically formulated into an oil-based vehicle and delivered in a general dosage form such as an oral capsule or an injectable solution. This particular oral formulation is recognized for its unique absorption pathway via the lymphatic system, distinguishing it from standard, unmodified oral Testosterone preparations. When administered correctly, these testosterone preparations are intended to achieve replacement goals and address hormone deficiencies in men.


What is the General Purpose of Testosterone Replacement?

The general purpose of Virigen is to provide essential testosterone replacement to correct a hormone deficiency syndrome. When the body fails to produce sufficient levels of the endogenous hormone, a condition referred to as hypogonadism, the administration of this androgen restores necessary systemic levels. A typical scenario involves using the medication to address symptoms related to hormone decline in adult males, such as persistent fatigue or loss of muscle mass, where laboratory testing confirms low Testosterone levels. The overarching therapeutic aim is to support and restore the androgen-dependent functions of the body, utilizing its intrinsic anabolic effect to promote protein synthesis and maintain overall biological health.

Regulatory References

  1. WHO Essential Medicines List
  2. Androgen Physiology: Receptor and Metabolic Disorders (NCBI Bookshelf)

What side effects are possible with Virigen (Testosterone)?

Possible side effects and safety information

The official safety profile of Testosterone replacement therapy, classified as an Androgen and Anabolic steroid, is structured around adverse reactions categorized by frequency and the physiological system affected, based on regulatory documentation from the FDA and European agencies.

Adverse Reaction Categories

Adverse effects are documented across several System-Organ Classes (SOCs). These include Blood and the Lymphatic System Disorders, frequently reporting an increase in hematocrit and hemoglobin, a condition known as Polycythemia. Vascular Disorders and Reproductive System Disorders are also key areas of focus, listing effects such as Hypertension (high blood pressure) and increases in Prostatic Specific Antigen (PSA), which may indicate Prostatomegaly (enlarged prostate).

Reactions classified as Most Common or frequently reported in clinical trials include Hypertension, increased hematocrit, increased weight, acne, and fatigue. Serious adverse reactions, as defined in regulatory labeling, include the risk of Venous Thromboembolism (VTE), potential Pulmonary Oil Microembolism (POME) with injectable formulations, and the documented possibility of benign and malignant Liver tumours.

Population-Specific Safety Notes

Safety statements specify particular considerations for certain groups. Geriatric patients may be at increased risk for the worsening of benign prostatic hyperplasia (BPH) and hypertension. For patients with underlying cardiac, renal, or hepatic disease, there is an increased risk of Edema (fluid retention) and/or Congestive Heart Failure (CHF). The therapy is contraindicated in men with known or suspected prostate or breast carcinoma, reflecting a key safety restriction.

Overdose and Emergency Response

Overdose and when to seek help

Overdose involving Virigen (Testosterone) is officially documented as resulting from serum testosterone concentrations exceeding the normal physiological range. Excess levels may manifest as increased irritability, nervousness, or weight gain. Specific symptoms of androgenic overexposure that require attention include long-lasting or frequent erections (priapism).


When to Seek Immediate Medical Help

Immediate medical attention is required if high-dose exposure leads to acute, life-threatening cardiovascular symptoms. Patients must seek medical attention immediately upon experiencing signs such as chest pain, shortness of breath or trouble breathing, weakness in one part or one side of the body, or slurred speech. Regulatory documents confirm that high-dose use and abuse are associated with severe outcomes, including myocardial infarction (heart attack) and stroke.


The official management approach for confirmed over-exposure is primarily procedural and non-antidotal. If laboratory testing shows serum levels are above the normal limits, the mandated action is the discontinuation of therapy or an immediate reduction in the administered dose. Symptomatic and supportive treatment is the general approach to manage any clinical manifestations.

Therapeutic Uses of Virigen (Testosterone)

What Virigen (Testosterone) Treats: Main Uses and Benefits

Virigen (Testosterone) is generally applied as a therapeutic option for men with hypogonadism, a condition where low testosterone levels are caused by specific medical disorders of the testicles, pituitary gland, or brain. The medication is primarily indicated to address this hormone deficiency.

Used for Management of Symptom Clusters and Supporting Stability

Testosterone therapy is relevant in contexts marked by increased discomfort or tension, addressing symptom clusters related to systemic imbalance and physiological strain. It is commonly used when symptoms intensify and may temporarily interfere with routine activities or cause functional strain, which may include symptoms such as low libido, fatigue, and reduced muscle mass.

“The therapy is applied to assist with maintaining functional stability and contributing to easing the overall symptom load during periods of heightened symptoms.”

Quick Fact: Assistance for Functional Strain

Virigen is applied across domains where additional symptomatic support is needed, supporting patients during episodes of heightened discomfort and helping improve day-to-day comfort. This is particularly relevant in conditions involving episodic or fluctuating manifestations where symptoms escalate temporarily.

Eligibility and Restrictions for Use

Eligibility for Virigen (Testosterone) is strictly defined by regulatory authorities. The use of this medicine is permitted only in adult males with a confirmed diagnosis of primary or hypogonadotropic hypogonadism.

Use is absolutely contraindicated in men with known or suspected carcinoma of the prostate or male breast carcinoma. It is also contraindicated for all pregnant women due to the risk of fetal harm.

The medicine is not established and not recommended for pediatric patients (under 18 years). Use is restricted in the geriatric population, particularly due to the potential for worsening Benign Prostatic Hyperplasia (BPH) and hypertension.

Conditional use and strict monitoring are required for patients with pre-existing cardiac, renal, or hepatic disease. These restrictions are imposed due to the labeled risk of fluid retention and potential for congestive heart failure. Use is also not recommended in men with uncontrolled hypertension.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns between Testosterone (the active ingredient in Virigen) and other medicines or products, based strictly on government regulatory documents.

Testosterone engages in both pharmacokinetic and pharmacodynamic interactions.

Drug–Drug Interactions Affecting Exposure

The co-administration of certain medicinal products can modify the systemic exposure of the androgen. Strong CYP3A4 inhibitors may increase the plasma concentration of Testosterone. Conversely, co-administration with hepatic enzyme inducers, such as Barbiturates, may result in reduced systemic exposure.

Pharmacodynamic Interactions and Monitoring

Testosterone is documented to potentiate the activity of coumarin-derived oral anticoagulants, such as Warfarin, requiring close monitoring of coagulation parameters. Additionally, co-administration with Corticosteroids or ACTH may increase the risk of fluid retention (edema). Androgens may also affect glucose metabolism, potentially necessitating a change in the dosage of Insulin or other antidiabetic agents.

Drug–Food Interaction

The oral capsule formulation of this medicine has a mandatory administration requirement. To ensure proper absorption and therapeutic exposure, the product must be taken with a meal containing fat.

Mechanism of Action

Virigen, containing Testosterone, functions as an androgen receptor (AR) agonist. After passive diffusion across the cell membrane, Testosterone or its 5alpha-reduced metabolite, dihydrotestosterone (DHT), binds to the intracellular AR, a member of the nuclear receptor superfamily.

Upon ligand binding, the AR undergoes a conformational change, dissociates from heat shock proteins, and translocates into the nucleus. The activated ligand-receptor complex then dimerizes and binds to specific DNA sequences known as Androgen Response Elements (AREs) in the promoter regions of target genes. This binding modulates gene transcription, leading to changes in the messenger RNA (mRNA) levels of various proteins.

This genomic pathway dictates the intracellular consequences, ultimately regulating the synthesis of proteins involved in numerous physiological processes, including the modulation of muscle and bone anabolism, erythropoiesis, and nitrogen retention at the system-level.

Dosage and Administration Information

Administration and Dosing of Virigen (Testosterone Undecanoate Capsules)

Route and Timing: Virigen (Testosterone Undecanoate) is administered orally and must be taken with food (specifically a meal) to ensure proper absorption, as bioavailability is highly dependent on dietary fat. The capsules should be swallowed whole with fluid and should not be chewed. For a total daily dose greater than 100 mg, the same dose is typically administered in the morning and evening.

Dosing Schedule: Dosing is individualized based on the patient's measured testosterone concentrations. The recommended starting dose for many products is 200 mg taken orally twice daily (in the morning and evening). Dosage adjustment is critical and must be guided by laboratory results.

Administration Step General Guideline
Prior to Initiation Confirm hypogonadism by measuring morning serum testosterone concentrations on at least two separate days, ensuring results are below the normal range.
Dose Adjustment Monitoring Check serum testosterone concentrations 3 to 6 hours after the morning dose approximately 7 days after starting treatment or following any dosage adjustment.
Missed Dose If a dose is forgotten, take it as soon as remembered. Do not take a double dose to compensate for the missed one; resume the regular dosing schedule.

Age-Specific Use: This oral testosterone therapy is indicated for replacement therapy in adult males with hypogonadism. Its safety and effectiveness have not been established for use in males under 18 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Virigen (Testosterone)

The research available for Virigen (Testosterone) is based on clinical trials and extended observational studies that examined its application in men diagnosed with Testosterone Deficiency Syndrome (Hypogonadism). The evidence helps contextualize what has been observed so far, focusing on changes measured during the study period rather than individual predictions.


Evidence for Use in Male Hypogonadism (Testosterone Deficiency Syndrome)

Core research consists of Randomized Controlled Trials (RCTs) and Meta-Analyses. These studies focused on outcomes related to sexual function (desire and erectile measures), body composition (lean mass and fat mass changes), and changes in general symptom severity. Trials monitored men randomized to receive the therapy or a comparator, such as a placebo.

In these studies, findings describe patterns observed in the populations. Research explored whether patterns of change were observed in the body’s physical structure and described the evolution of symptoms over defined time intervals. Data for certain subjective outcomes, such as reports of energy and mood changes, demonstrate variability across trials.

Studies Examining Metabolic and Endocrine Outcomes

Studies consistently monitored the therapy’s impact on circulating hormone levels, reporting that the treatment was associated with the achievement and maintenance of serum testosterone concentrations within the desired range. Additionally, research examined the relationship between the therapy and metabolic outcomes in specific cohorts, such as those with Type 2 Diabetes Mellitus. These studies monitored biomarkers like HbA1c (blood sugar control) and specific lipid profiles.

Long-Term Data and Research Gaps

While many core efficacy trials had follow-up durations limited to one year or less, the research landscape includes data from long-term observational studies tracking patient patterns for up to 12 years. However, the long-term effects are not fully established by the same gold standard of evidence that supports the short-term findings. Research for specific populations, such as older men with age-related decline, is limited, and further research is needed regarding major health endpoints tracked over many years.

Key Studies & References Testosterone Systemic (MedlinePlus) — Drug Information

Frequently Asked Questions (FAQ)

Common questions about Virigen (Testosterone) (FAQ)


Q: How quickly does Virigen start working after you begin using it?

A: Official product information states that serum testosterone concentrations are monitored within 3 to 6 hours after the morning dose around 7 days after starting treatment or following any dosage adjustment. This monitoring timeline helps a healthcare provider determine whether the therapy is achieving the appropriate blood levels.

Q: Are there any common side effects people worry about with Virigen?

A: Regulatory documents list side effects based on what was commonly reported in clinical trials. These frequently reported reactions include an increase in hematocrit (red blood cell count), increased weight, acne, fatigue, and hypertension (high blood pressure).

Q: What happens if I miss a dose of Virigen?

A: The patient information describes that if a dose is forgotten, the direction is to take it as soon as it is remembered. It is specifically directed that you should not take a double dose to make up for the missed one, but rather resume the regular dosing schedule afterward.

Q: Is it normal to feel a change in my libido after starting Virigen?

A: Changes in sexual desire are noted in the official safety profile. Increased sexual desire is listed as an uncommon side effect. Additionally, the medicine is used to address symptoms of low testosterone, which often include a decreased libido.

Q: Does using Virigen affect cholesterol levels?

A: Studies and official information indicate that the medicine may affect the serum lipid profile. Specifically, decreases in high-density lipoprotein (HDL) cholesterol and increases in both total cholesterol and triglycerides have been reported in the product's safety data.

Q: Does Virigen cause water retention?

A: Official documents note that fluid retention, known as edema, may occur with this type of therapy. Official documentation notes this risk is increased for individuals with pre-existing conditions affecting the heart, kidneys, or liver.

Q: Can Virigen cause changes to my skin or hair?

A: Yes, changes to the skin and hair have been reported. Acne is listed as a commonly reported side effect. Changes to hair, such as alopecia (hair loss), have been reported as uncommon side effects in the official safety documents.

Q: Is Virigen the same as taking testosterone naturally?

A: No. Virigen contains a synthetic derivative of the body's naturally occurring testosterone hormone. It is designed to act similarly to the body's own hormone, replacing it when the body fails to produce sufficient levels.

Q: Does Virigen affect mood or energy levels?

A: Official safety documents indicate that effects on mood have been reported, listed as uncommon. These include emotional disorder, restlessness, irritability, aggression, and depression. Fatigue is also a commonly reported side effect.

Q: What is the difference between Virigen and other testosterone products like gels or patches?

A: The primary difference lies in the formulation and administration route. Regulatory documents define Virigen as an oral capsule that must be taken with a meal for proper absorption, which distinguishes it from topical products (like gels or patches) or injectable forms.

Q: Is it true that Virigen might affect fertility?

A: Official safety information notes that testosterone therapy has the potential for adverse effects on sperm production (spermatogenesis). The documented potential for adverse effects on sperm production includes the possibility of causing azoospermia (the absence of sperm).

Q: What kind of studies support the use of Virigen?

A: The use of the drug is supported by evidence from controlled clinical investigations. These typically include Randomized Controlled Trials (RCTs) that examine the drug's effectiveness in men diagnosed with hypogonadism.

Q: Is Virigen a controlled substance?

A: Yes. The active ingredient, Testosterone, is classified in the United States as a Schedule III controlled substance under federal regulation.

Q: How is Virigen different from supplements that claim to boost testosterone?

A: Virigen is a prescription medication that is FDA-approved for treating specific medical conditions, namely confirmed hypogonadism. Unlike dietary supplements, Virigen is a prescription medication that has undergone the required official approval process for treating a specific medical condition.

Q: Are there certain foods or drinks I should avoid while on Virigen?

A: The medicine must be taken with a meal to ensure proper absorption, as described in the official instructions. Regulatory documents do not specifically list particular foods or drinks that must be avoided, other than the requirement to take the medication with a meal.

Q: Why do official sources list so many possible side effects for Virigen?

A: Official drug labels are required by regulation to report all adverse events observed during clinical trials. These effects are often listed by their frequency and the physiological system they affect, which provides a comprehensive overview of the product’s safety profile.

Q: Does Virigen interfere with sleep?

A: Official safety information notes two potential effects related to sleep. The medicine may potentiate sleep apnea (a condition where breathing stops and starts during sleep) in patients with risk factors. Insomnia (difficulty sleeping) is also reported as an uncommon side effect.

Q: What should I do if I suspect an interaction between Virigen and another drug?

A: The patient counseling information advises informing a healthcare provider or pharmacist if an interaction is suspected or when planning to start a new medicine.

Q: Can using Virigen lead to mood swings or irritability?

A: Official safety documents indicate that mood swings and irritability have been reported as adverse reactions in clinical studies for this class of medicine.

Q: How do I know if the low testosterone I have is the kind Virigen treats?

A: The medicine is officially approved for conditions associated with a deficiency or absence of testosterone due to either Primary hypogonadism or Hypogonadotropic hypogonadism. The official distinction between these two types of low testosterone is based on laboratory testing, which is required prior to starting therapy.

Q: Does Virigen have an effect on bone density?

A: The hormone testosterone has an anabolic effect that helps regulate bone growth and maintenance, as described in the mechanism of action. Official studies have included the monitoring of changes in bone mineral density as part of the evidence base for the therapy.

Q: Is Virigen prescribed for conditions besides hypogonadism?

A: According to the official label, the medicine is only indicated for replacement therapy in adult males with conditions associated with a deficiency or absence of endogenous testosterone, which is medically termed hypogonadism.

How should Virigen (Testosterone) be stored and disposed of?

Storage and Disposal of Virigen (Testosterone)

Testosterone medication must be stored according to regulatory requirements to ensure its stability and patient safety.


Storage Conditions and Protection

Store the product at Controlled Room Temperature, which is 20° to 25°C (68° to 77°F). The medication must be protected from light and, for capsule forms, stored in a dry place to avoid moisture exposure. If the injectable solution forms crystals, the labeled handling requirement is to dissolve them by warming and shaking the vial.

Handling and Discarding

All testosterone products must be kept out of the sight and reach of children and stored in a secure location. For single-dose injectable vials, any unused portion must be discarded immediately after use. Patients should ask a healthcare professional or pharmacist about the correct procedures for disposing of unused or expired medicine in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Virigen (Testosterone) found in:

A-Z Index: